February 16, 2021
Japan’s first biosimilar for AbbVie’s anti-TNF-α monoclonal antibody Humira (adalimumab) was launched on February 15 by Fujifilm Kyowa Kirin Biologics and its sales partner Mylan EPD. Fujifilm Kyowa Kirin earned approval for its Adalimumab BS Subcutaneous Injection “FKB” in June...read more